An Iowa Medicaid billing change the state says is required by federal law is drawing sharp criticism from pediatric therapy ...

Boomerang Portfolio Company Closes Add-On Acquisition, Expanding the Platform's Market Reach & Capabilities for Health Systems Across the Country NASHVILLE, Tenn., Dec. 16, 2025 /PRNewswire/ -- Enjoin ...

New procedural codes establish standardized pathway for clinical use of autologous heterogeneous skin construct across care ...

Meta Platforms leads today???s Zacks Research Daily as AI-driven engagement and ad demand fuel growth, even as heavy AI ...

Meta Platforms leads today's Zacks Research Daily as analysts highlight strong user growth, heavier AI investment and ...

Parents across the country are waking up to a childhood vaccine schedule that looks very different from the one they have ...

Omeros to Host Conference Call Monday, December 29, 2025 at 4:30 p.m. ET -- -- First and only approved option: YARTEMLEA(R) is the only approved treatment for hematopoietic stem cell ...

The U.S. FDA has approved narsoplimab (Yartemlea) as the first indicated therapy for hematopoietic stem cell ...

In 2026, residents in Virginia, Maryland, and Washington, D.C., will see significant changes as a range of new laws go into ...

Omeros Corporation today announced that the U.S. Food and Drug Administration (FDA) has approved YARTEMLEA® (narsoplimab-wuug) for the treatment of hematopoietic stem cell transplant-associated ...

Speech therapists say a change to Iowa Medicaid reimbursement rates could reduce services and make wait lists longer.

An upcoming adjustment to how much behavioral health providers get paid through Oregon’s Medicaid infrastructure could put ...